[HTML][HTML] AI and precision oncology in clinical cancer genomics: From prevention to targeted cancer therapies-an outcomes based patient care
Precision medicine is the personalization of medicine to suit a specific group of people or
even an individual patient, based on genetic or molecular profiling. This can be done using …
even an individual patient, based on genetic or molecular profiling. This can be done using …
Proteomics-based identification of dysregulated proteins in breast cancer
Immunohistochemistry (IHC) is still widely used as a morphology-based assay for in situ
analysis of target proteins as specific tumor antigens. However, as a very heterogeneous …
analysis of target proteins as specific tumor antigens. However, as a very heterogeneous …
Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway
Background Chemoresistance involves metastasis and aggressiveness of breast cancer
(BC). Chemotherapy-elicited exosomes have been reported to be associated with drug …
(BC). Chemotherapy-elicited exosomes have been reported to be associated with drug …
Asymmetrically split DNAzyme-based colorimetric and electrochemical dual-modal biosensor for detection of breast cancer exosomal surface proteins
W Cheng, Y Yao, D Li, C Duan, Z Wang… - Biosensors and …, 2023 - Elsevier
Exosomal surface proteins are potentially useful for breast cancer diagnosis and awareness
of risk. However, some detection techniques involving complex operations and expensive …
of risk. However, some detection techniques involving complex operations and expensive …
Proteomics-Based identification of dysregulated proteins and biomarker discovery in invasive ductal carcinoma, the most common breast cancer subtype
Invasive ductal carcinoma (IDC) is the most common histological subtype of malignant
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …
Onco-Breastomics: An Eco-Evo-Devo Holistic Approach
Known as a diverse collection of neoplastic diseases, breast cancer (BC) can be
hyperbolically characterized as a dynamic pseudo-organ, a living organism able to build a …
hyperbolically characterized as a dynamic pseudo-organ, a living organism able to build a …
Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics
Introduction Breast cancer is one of the most prevalent cancers among women in the United
States. Current research regarding breast milk has been focused on the composition and its …
States. Current research regarding breast milk has been focused on the composition and its …
Recent Contributions of Mass Spectrometry-Based “Omics” in the Studies of Breast Cancer
Breast cancer (BC) is one of the most heterogeneous groups of cancer. As every biotype of
BC is unique and presents a particular “omic” signature, they are increasingly characterized …
BC is unique and presents a particular “omic” signature, they are increasingly characterized …
Application of artificial intelligence in the diagnosis, treatment, and recurrence prediction of peritoneal carcinomatosis
GX Wei, YW Zhou, ZP Li, M Qiu - Heliyon, 2024 - cell.com
Peritoneal carcinomatosis (PC) is a type of secondary cancer which is not sensitive to
conventional intravenous chemotherapy. Treatment strategies for PC are usually palliative …
conventional intravenous chemotherapy. Treatment strategies for PC are usually palliative …
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines
M Sanz-Álvarez, M Luque, M Morales-Gallego… - International Journal of …, 2023 - mdpi.com
The combination of trastuzumab and pertuzumab as first-line therapy in patients with HER2-
positive breast cancer has shown significant clinical benefits compared to trastuzumab …
positive breast cancer has shown significant clinical benefits compared to trastuzumab …